liquid biopsy

Thermo Fisher’s Luca Quagliata also discusses pathologists’ desire for rapid turnaround times

As liquid biopsy becomes a standard tool in oncology, distinguishing tumor signals from clonal hematopoiesis is essential for accurate results

How are new diagnostic tools changing cancer screening?

Insight into the strengths, limitations, and clinical utility of liquid biopsy for molecular profiling and residual disease detection

The customized solution enables the team to make informed variant interpretations and treatment recommendations

Researchers have found that a test to detect circulating tumor DNA can predict lung cancer outcome

Screening successes, emerging technologies, precision treatments, and other steps forward from the AACR Cancer Progress Report 2024

The blood test that uses artificial intelligence (AI) to detect cancer-related genetic changes and protein biomarkers could help screen women for early signs of ovarian cancer

Trailblazing labs are among the first to adopt new tests and treatments for longstanding challenges

An analytical tool called EV fingerprinting could soon replace traditional invasive biopsies for certain diseases